SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-028420
Filing Date
2021-05-17
Accepted
2021-05-17 16:28:10
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cere-10q_20210331.htm 10-Q 2227347
2 EX-10.1 cere-ex101_322.htm EX-10.1 400393
3 EX-10.2 cere-ex102_421.htm EX-10.2 391254
4 EX-10.3 cere-ex103_137.htm EX-10.3 74971
5 EX-10.5 cere-ex105_136.htm EX-10.5 28730
6 EX-31.1 cere-ex311_6.htm EX-31.1 20364
7 EX-31.2 cere-ex312_7.htm EX-31.2 20331
8 EX-32.1 cere-ex321_8.htm EX-32.1 9603
9 EX-32.2 cere-ex322_9.htm EX-32.2 9588
10 GRAPHIC g4jdnicbof0d000001.jpg GRAPHIC 102858
11 GRAPHIC g2vnumqj0mos000001.jpg GRAPHIC 37411
  Complete submission text file 0001564590-21-028420.txt   7528552

Data Files

Seq Description Document Type Size
12 XBRL INSTANCE DOCUMENT cere-20210331.xml EX-101.INS 1188101
13 XBRL TAXONOMY EXTENSION SCHEMA cere-20210331.xsd EX-101.SCH 49107
14 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cere-20210331_cal.xml EX-101.CAL 39189
15 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cere-20210331_def.xml EX-101.DEF 158205
16 XBRL TAXONOMY EXTENSION LABEL LINKBASE cere-20210331_lab.xml EX-101.LAB 363124
17 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cere-20210331_pre.xml EX-101.PRE 280903
Mailing Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116
Business Address 131 DARTMOUTH STREET SUITE 502 BOSTON MA 02116 844-304-2048
Cerevel Therapeutics Holdings, Inc. (Filer) CIK: 0001805387 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39311 | Film No.: 21931230
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences